Qianzhu Xu

机构：Fudan University · ORCID：0000-0001-7325-6822

发表论文 9 篇 · 总被引 321 次 · h-index 9

代表论文

• Drug Nanocrystals for Active Tumor-Targeted Drug Delivery (2022 · Pharmaceutics · 被引 56)
• All-stage targeted therapy for glioblastoma based on lipid membrane coated cabazitaxel nanocrystals (2022 · Journal of Controlled Release · 被引 47)
• All-stage targeted red blood cell membrane-coated docetaxel nanocrystals for glioma treatment (2024 · Journal of Controlled Release · 被引 37)
• Engineered platelets-based drug delivery platform for targeted thrombolysis (2022 · Acta Pharmaceutica Sinica B · 被引 36)
• Hydrogel loading functionalized PAMAM/shRNA complex for postsurgical glioblastoma treatment (2021 · Journal of Controlled Release · 被引 36)
• In vivo self-assembled drug nanocrystals for metastatic breast cancer all-stage targeted therapy (2022 · Journal of Controlled Release · 被引 32)